Figure 1.

Kaplan-Meier survival estimate. c.35 G > A KRAS mutant patients versus KRAS wild-type patients. 1, progression-free survival; 2, overall survival.

Bruera et al. BMC Medicine 2013 11:59   doi:10.1186/1741-7015-11-59
Download authors' original image